Tactogen

Developing new MDMA-like medicines for effective prescription mental wellness

Print
Claim My Business
Form C
View on Wefunder
Security Type
CAFES
Categories
Retail, Consumer Goods & Products, Healthcare & Medical
Min Investment
$100
Location
Palo Alto, CA
Expected Close Date
April 30, 2023
Target Raise
$50.00K-$5.00M
No. Investors
167
Security Price
$1
Website
tactogen.com
Number of Employees
4
Cash
$1,784,371
Revenue
$0
Short Term Debt
$136,981
Cost of Goods
$0
Long Term Debt
$0
Net Income
$-2,483,543

Key Deal Facts

Tactogen is a public benefit corporation making entactogen (MDMA-like) molecules.
CEO leverages 30+ years of experience in psychedelic preclinical and clinical research.
Many lead compounds ready for safety and toxicity studies. $2-4 million will complete that process.
Raised $6.3 million over 2.5 years from well known investors.
Significant potential to improve mental health treatment for millions of people.

Management Team / Advisory Board Bios

Matthew Baggott CEOSeasoned Ph.D. neuroscientist and data science leader with comprehensive knowledge of psychedelic science and a 30-year career spanning data science, preclinical pharmacology, clinical research, neuroscience, genomics, and drug development., Luke Pustejovsky COOFrontier tech entrepreneur with VC experience. 25+ year career partnering with leading scientists to commercialize breakthrough solutions. Advisor to Psychedelic.support and climate tech innovators., Scarlet Masius Head of CommunityScarlet's work exists at the intersection of immersive experience design, community building, psychedelics and social impact. They are on the board of North Star Project., Travis Mowbray Senior Clinical Trial ManagerTravis was the Global Trial Director for The Janssen Pharmaceutical Companies of Johnson & Johnson. He is deeply experienced in clinical research processes., Jeremy Coyle Senior Data ScientistJeremy Coyle, Ph.D., is a data scientist, biostatistician, and programmer. He is primary author of the tlverse, an extensible ecosystem of R packages for targeted causal machine learning., Arjun Mukerji Data ScientistArjun Mukerji is completing his Ph.D. in neuroscience at the Michael Silver Lab at UC Berkeley., Laina Zarek Durbin
Amount Raised : $96,592
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment